The effect of diclofenac on proliferation and production of growth factors by endothelial cells (HMEC-1) under hypoxia and inflammatory conditions

Acta Pharmaceutica

Volumn 64, Issue 1, 2014, Pages 131-138

  Wiktorowska Owczarek, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

BFGF; Diclofenac; Endothelial cells; Hypoxia; LPS; VEGF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; COBALT CHLORIDE; DICLOFENAC; PROSTAGLANDIN SYNTHASE INHIBITOR; VASCULOTROPIN; SIGNAL PEPTIDE;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MICROVASCULAR ENDOTHELIAL CELL; PARACRINE SIGNALING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STIMULATION; BIOSYNTHESIS; CELL CULTURE; CELL HYPOXIA; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME;

CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TREATMENT OUTCOME;

EID: 84904206517     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/acph-2014-0006     Document Type: Article

References (22)

1. S. John, M. Schlaich, M. Langenfeld, H. Weihprecht, G. Schmitz, G. Weidinger and R. E. Schmieder, Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study, Circulation 98 (1998) 211-216; DOI: org/10.1161/01.CIR.98.3.211
2. C. Golias, A. Batistattou, G. Bablekos, A. Charalabopoulos, D. Peschos, P. Mitsopoulos and K. Charalabopoulos, Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis, Cell. Commun. Adhes. 18 (2011) 19-32; DOI: org/10.3109/15419061.2011.606381
3. O. Ciftci, M. Caliskan, H. Gullu, D. Erdogan, S. Topcu, O. Guler, A. Yildirir and A. H. Muderrisoglu, Acute effects of smoking light cigarettes on coronary microvascular functions, Clin. Cardiol. 32 (2009) 210-214; DOI: org/10.1002/clc.20343
4. S. Kosaka, N. Pelisch, M. Rahman, D. Nakano, H. Hitomi, H. Kobori, N. Fukuoka, H. Kobara, H. Mori, T. Masaki, L. Cervenka, Y. Matsumura, H. Houchi and A. Nishivama, Effects of angiotensin II AT(1)-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats, J. Pharmacol. Sci. 121 (2013) 95-102
5. G. Y. Belgore, H. Lip and A. D. Blann, Basic fibroblast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells, Eur. J. Clin. Invest. 33 (2003) 833-839; DOI: 10.1046/j.1365-2362.2003.01223.x
6. C. Muraki, N. Ohga, Y. Hida, H. Nishihara, Y. Kato, K. Tsuchiya, K. Matsuda, Y. Totsuka, M. Shindoh and K. Hida, Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells, Int. J. Cancer 130 (2012): 59-70; DOI: org/10.1002/ijc.25976
7. A. M. Olsen, E. L. Fosbøl, J. Lindhardsen, C. Andersson, F. Folke, M. B. Nielsen, L. Køber, P. R. Hansen, C. Torp-Pedersen, G. H. Gislason; Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients -a nationwide study, PLoS One 8 (2013):e54309; DOI: 10.1371/journal.pone.0054309
8. N. Bhala, J. Emberson, A. Merhi, S. Abramson, N. Arber, J. A. Baron, C. Bombardier, C. Cannon, M. E. Farkouh, G. A. FitzGerald, P. Goss, H. Halls, E. Hawk, C. Hawkey, C. Hennekens, M. Hochberg, L. E. Holland, P. M. Kearney, L. Laine, A. Lanas, P. Lance, A. Laupacis, J. Oates, C. Patrono, T. J. Schnitzer, S. Solomon, P. Tugwell, K. Wilson, J. Wittes and C. Baigent, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet 31 (2013) 769-779; DOI: 10.1016/S0140-6736(13)60900-9
9. H. C. Yao, T. Liu, X. Y. Meng, Q. F. Han, M. Zhang and L. X. Wang, Effect of basic fibroblast growth factor on the myocardial expression of hypoxia-inducible factor-1a and vascular endothelial growth factor following acute myocardial infarction, Heart Lung Circ. (in press); DOI: 10.1016/j.hlc.2013.04.111
10. S. Wu, X. Wu, W. Zhu, W. J. Cai, J. Schaper and W. Schaper, Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis, Mol. Cell. Biochem. 343 (2010) 223-229; DOI: 10.1007/s11010-010-0517-3
11. J. A. Paramo, J. A. Rodriguez, O. Beloqui and J. Orbe, Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis? Current Drug Targets-Cardiovasc. Haemat. Dis. 5 (2005) 303-311; DOI: org/10.2174/1568006054553381
12. A. Cucina, V. Borrelli, B. Randone, P. Coluccia, P. Sapienza and A. Cavallaro, Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells, J. Surg. Res. 109 (2003) 16-23; DOI: org/10.1016/S0022-4804(02)00042-2
13. S. Flis, D. Soltysiak-Pawluczuk, A. Jedrych, Z. Jastrzebski, M. Remiszewska and J. Splawinski, Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest, Anticancer Res. 26 (2006) 3033-3042
14. Q. Chen, W. L. Liu, X. Guo, Y. J. Li and Z. G. Guo, Biphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanism, Acta Pharmacol. Sin. 28 (2007) 353-358; DOI: org/10.1111/j.1745-7254. 2007.00518.x
15. E. Niederburger, C. Manderscheid, S. Grosch, H. Schmidt, C. Ehnert and G. Geisslinger, Effects of selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells, Biochem. Pharmacol. 68 (2004) 341-350; DOI: org/10.1016/j.bcp.2004.03.029
16. S. Boonmasawai, P. Akarasereenont, K. Techatraisak, A. Thaworn, S. Chotewuttakorn and T. Palo, Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture, J. Med. Assoc. Thai 92 (2009) 1508-1515
17. P. Akarasereenont, Y. S. Bakhle, C. Thiemermann and J. R. Vane, Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide, Br. J. Pharmacol. 115 (1995) 401-408; DOI: 10.1111/j.1476-5381.1995. tb16347.x
18. M. Namiecinska, A. Wiktorowska-Owczarek, A. Loboda, J. Dulak and J. Z. Nowak, Cyclic AMP generating system in human microvascular endothelium is highly responsive to adrenaline, Pharmacol. Rep. 58 (2006) 884-889
19. A. Loboda, A. Jazwa, B. Wegiel, A. Jozkowicz and J. Dulak, Heme oxygenase-1-dependent and -independent regulation of angiogenic expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells, Cell. Mol. Biol. 51 (2005) 347-355
20. A. Loboda, A. Jazwa, A. Jozkowicz, G. Molema and J. Dulak, Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin, Vascul. Pharmacol. 44 (2006) 206-214; DOI: org/10.1016/j.vph.2005.11.007
21. F. Grasselli, G. Basini, S. Bussolati and F. Bianco, Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulose cells, Reprod. Fer. Dev. 17 (2005) 715-720
22. A. Wiktorowska-Owczarek, M. Józbwiak-Bezbenista and J. Z. Nowak, Effects of hypoxia on cyclic AMP signaling and VEGF/bFGF generation in different types of cultured cells, Pharmacol. Rep. 63 (2011) 574-575.